Rising Commercialization of Cell and Gene Therapies Boosts the Automated and Closed Cell Therapy Pro

Author : Eknath Girhepunje | Published On : 25 Jun 2026

Automated and Closed Cell Therapy Processing Systems Market

The global automated and closed cell therapy processing systems market is witnessing rapid expansion due to increasing commercialization of cell and gene therapies, growing demand for standardized manufacturing processes, and advancements in automated bioprocessing technologies. The global automated and closed cell therapy processing systems market size is valued at USD 1.64 billion in 2025 and is estimated to reach USD 7.61 billion by 2034, growing at a CAGR of 18.62% during the forecast period. The robust market growth is fueled by the expanding adoption of microfluidic sensor-embedded closed modules, which enable real-time sterility assurance during cell manipulation workflows in regulated production environments.

Automated and closed cell therapy processing systems are designed to streamline cell isolation, expansion, modification, harvesting, and formulation within a fully enclosed environment. These systems minimize contamination risks, improve manufacturing consistency, reduce manual intervention, and support compliance with stringent regulatory standards. As the demand for advanced cell therapies continues to rise, automated processing platforms are becoming critical for scalable and cost-efficient production.

For detailed market insights, growth forecasts, and competitive analysis, visit:
https://straitsresearch.com/report/automated-and-closed-cell-therapy-processing-systems-market

Market Drivers

Rising Adoption of Cell and Gene Therapies

The increasing number of approved cell and gene therapies is driving demand for advanced processing technologies capable of delivering consistent product quality. Pharmaceutical companies and biotechnology firms are investing heavily in automated manufacturing systems to support commercial-scale production.

Automated and closed processing platforms reduce contamination risks while improving reproducibility throughout complex cell therapy workflows.

Growing Demand for Sterile Manufacturing Solutions

Maintaining sterility is one of the most critical requirements in cell therapy production. Closed processing systems eliminate many contamination risks associated with open laboratory procedures and help manufacturers comply with Good Manufacturing Practice (GMP) standards.

The integration of microfluidic sensor technologies enables continuous monitoring of production environments, further improving process reliability and product safety.

Technological Advancements in Bioprocess Automation

Continuous innovation in automation, robotics, digital monitoring, and artificial intelligence is transforming cell therapy manufacturing. Modern processing platforms integrate multiple production steps into a single automated workflow, improving efficiency while reducing labor costs.

These technological advancements are accelerating the adoption of automated processing systems across research laboratories and commercial manufacturing facilities.

Market Challenges

High Capital Investment Requirements

Implementing automated and closed processing systems requires substantial investment in specialized equipment, facility upgrades, and workforce training. These costs may limit adoption among smaller biotechnology companies and academic research institutions.

Manufacturers continue developing scalable platforms to improve affordability and accessibility.

Complex Regulatory Compliance

Cell therapy manufacturing is subject to rigorous regulatory oversight to ensure product quality, patient safety, and manufacturing consistency. Companies must continuously validate automated systems and maintain compliance with evolving international regulations.

Meeting these requirements can increase operational complexity and product development timelines.

Market Segmentation

By Product Type

The market is segmented into automated processing systems, closed processing systems, consumables, and software solutions. Automated processing systems account for a significant market share due to increasing demand for standardized manufacturing and reduced manual intervention.

Consumables are also witnessing strong growth as recurring production activities require sterile single-use components.

By Application

The market serves applications including stem cell therapy, CAR-T cell therapy, gene-modified cell therapy, regenerative medicine, and clinical research. CAR-T cell therapy represents one of the fastest-growing application segments due to expanding commercialization and increasing regulatory approvals.

Stem cell processing also contributes significantly to market demand across research and therapeutic applications.

By End User

Biopharmaceutical companies remain the largest end-user segment because of increasing investments in commercial cell therapy manufacturing. Contract development and manufacturing organizations (CDMOs) also represent a major market segment as outsourcing continues to grow.

Academic research institutes and hospitals continue adopting automated systems to support clinical research and translational medicine.

Regional Insights

North America

North America dominates the automated and closed cell therapy processing systems market due to strong biotechnology research, increasing regulatory approvals for cell therapies, and substantial investments in advanced biomanufacturing technologies. The United States remains the largest contributor to regional growth.

Europe

Europe represents a major market supported by expanding regenerative medicine research, favorable government funding, and growing adoption of automated manufacturing platforms. Countries including Germany, the United Kingdom, and Switzerland continue investing in advanced cell therapy infrastructure.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth during the forecast period. Rapid expansion of biotechnology industries, increasing healthcare investments, and growing clinical research activities in China, Japan, South Korea, and India are driving regional demand.

Government initiatives supporting regenerative medicine further strengthen market growth.

Latin America, Middle East & Africa

These regions are gradually expanding their biotechnology capabilities through healthcare modernization and research investments. Growing participation in advanced therapy development is expected to create future market opportunities.

Key Players Analysis

The automated and closed cell therapy processing systems market is highly competitive, with leading companies focusing on automation technologies, integrated manufacturing platforms, and digital process monitoring. Manufacturers are investing in closed-system innovations, microfluidic technologies, and scalable production solutions to strengthen their competitive positions.

Strategic collaborations between biotechnology companies, equipment manufacturers, and research institutions continue to accelerate technological innovation and commercial adoption.

Key Companies

• Thermo Fisher Scientific Inc.

• Sartorius AG

• Cytiva

• Lonza Group AG

• Miltenyi Biotec

• Fresenius Kabi AG

• Terumo Blood and Cell Technologies

• Danaher Corporation

• Cell Processing Technologies

• Ori Biotech Ltd.

Conclusion

The global automated and closed cell therapy processing systems market is expected to witness exceptional growth through 2034, driven by increasing adoption of cell and gene therapies, rising demand for sterile automated manufacturing, and continuous advancements in bioprocess automation. Although high implementation costs and regulatory complexity remain challenges, expanding commercialization of advanced therapies and growing investments in biotechnology manufacturing are expected to create significant opportunities for market participants. As regenerative medicine continues to evolve, automated and closed processing systems will play a central role in delivering safe, scalable, and efficient cell therapy production.

About Us

Straits Research is a leading market research and intelligence organization specializing in research, analytics, and advisory services. The company provides comprehensive market reports, industry insights, and strategic business intelligence across multiple industries, helping organizations identify growth opportunities and make informed business decisions.

Contact Us

Email: [email protected]

Tel: +1 646 905 0080 (U.S.)

Tel: +44 203 695 0070 (U.K.)